Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Patrick Spangler Insider Profile
4 Followers
Patrick Spangler, Director at Urologix, holds 45.47K shares in OptimizeRx (Ticker: OPRX), holds 155.26K shares in Urologix (Ticker: ULGX), holds 0.00 shares in Epocrates (Ticker: EPOC).
Patrick Spangler has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Patrick Spangler
Patrick Spangler's Trading History
Urologix
Nov 21, 2014
Director
Uninformative Buy
―
$2.02K
OptimizeRx
Jun 11, 2024
Director
Uninformative Buy
263.34K
$215.97K
Epocrates
―
―
―
―
List of latest transactions for each holding click on a transaction to see Patrick Spangler's performance on stock
You May Also Like
Patrick Spangler insider profile FAQ
What is the percentage of profitable transactions made by Patrick Spangler?
The percentage of profitable transactions made by Patrick Spangler is ―.
What is the average return per transaction made by Patrick Spangler?
The average return per transaction made by Patrick Spangler is ―.
What stocks does Patrick Spangler hold?
Patrick Spangler holds: ULGX, OPRX, EPOC stocks.
What was Patrick Spangler’s latest transaction?
Patrick Spangler latest transaction was an Uninformative Buy of $263.34K.
What was Patrick Spangler's most profitable transaction?
Patrick Spangler’s most profitable transaction was an Informative Buy of OPRX stock on June 28, 2018. The return on the trade was 58.00%.
What is Patrick Spangler's role in Urologix?
Patrick Spangler's role in Urologix is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.